CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 319 enrolled
Drug / intervention
Intravenous ibuprofen +1 moredrug
Likely dose
Intravenous ibuprofen 800 mg diluted in 250 milliliters of normal saline administered every 6 hoursAI-extracted
Key inclusion· 4
  • Scheduled for elective abdominal hysterectomy with anticipated need for post-operative IV morphine analgesia for ≥24 hours
  • Age 18-70 years
  • Adequate IV access
  • Anticipated hospital stay ≥24 hours
Key exclusion· 10
  • Use of NSAIDs within 12 hours prior to dosing
  • Use of analgesics, muscle relaxants, or sedatives within 24 hours prior to treatment, with specified exceptions
  • Taking warfarin, lithium, or combination of ACE-inhibitors and furosemide
  • History of allergy or hypersensitivity to ibuprofen, aspirin, NSAIDs, or COX-2 inhibitors

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00225732
NCT00225732Phase 3Completed

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Injection (IVIb) for Treatment of Pain in the Post-Operative Adult Patients

Cumberland Pharmaceuticals·interventional·Posted Sep 26, 2005·Updated Jun 22, 2016

In Brief

A Phase 3 clinical trial evaluating Normal saline as placebo comparator and Intravenous ibuprofen for Pain. Completed, enrolled 319 participants across 13 sites in 2 countries.

Detailed Summary

The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for the narcotic analgesic, morphine, post surgery

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesAustralia, United States
Collaborators--

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 26, 2005
Enrollment StartJan 1, 2005
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 20.8 years ago

Interventions

Normal saline as placebo comparatorother

250 ml normal saline as a placebo comparator was administered every 6 hours for a total of eight doses over the first 48 hours. Those patients who received the initial eight doses could continue to receive additional doses as needed through the end of the treatment period (day 5)

Intravenous ibuprofendrug

800 mg intravenous ibuprofen diluted in 250 milliliters of normal saline was administered every 6 hours for a total of eight doses over the first 48 hours. Those patients who received the initial eight doses could continue to receive additional doses as needed through the end of the treatment period (day 5)